InvestorsHub Logo

Pineapple1

09/12/17 10:48 AM

#119751 RE: nidan7500 #119724

This from todays news suggests to me a level of organizational churn/movement/confusion/uncertainty/whatever, in BIIB. Point is, if you happen to be trying to negotiate with a company (like we think AVXL is w/BIIB) during a period of organizational churn then your plans will be in the churn along w/other things. Not a good time to try to finaize a deal



Related point today's news about FWD (forward Pharma)might be getting royalties from BIIB from Tecfideria, putting more pressure for them to get a deal together with Anavex. Yesterday's CC the CEO reiterated their desire to be the leader in Neurology space.